These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37188686)

  • 21. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of intracerebroventricular idursulfase-beta enzyme replacement therapy in mucopolysaccharidosis II murine model: heparan sulfate in cerebrospinal fluid as a clinical biomarker of neuropathology.
    Sohn YB; Ko AR; Seong MR; Lee S; Kim MR; Cho SY; Kim JS; Sakaguchi M; Nakazawa T; Kosuga M; Seo JH; Okuyama T; Jin DK
    J Inherit Metab Dis; 2018 Nov; 41(6):1235-1246. PubMed ID: 29978271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy.
    Miwa S; Watabe AM; Shimada Y; Higuchi T; Kobayashi H; Fukuda T; Kato F; Ida H; Ohashi T
    Mol Genet Metab; 2020 Aug; 130(4):262-273. PubMed ID: 32631737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in glycogen and glycosaminoglycan levels in hepatocytes of iduronate-2-sulfatase knockout mice before and after recombinant iduronate-2-sulfatase supplementation.
    Lee JH; Choe YH; Kim SJ; Paik KH; Jin DK
    Yonsei Med J; 2011 Mar; 52(2):263-7. PubMed ID: 21319344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil.
    Giugliani R; Martins AM; So S; Yamamoto T; Yamaoka M; Ikeda T; Tanizawa K; Sonoda H; Schmidt M; Sato Y
    Mol Ther; 2021 Jul; 29(7):2378-2386. PubMed ID: 33781915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II.
    Rybová J; Ledvinová J; Sikora J; Kuchař L; Dobrovolný R
    J Inherit Metab Dis; 2018 Mar; 41(2):221-229. PubMed ID: 29168031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations.
    Alves S; Mangas M; Prata MJ; Ribeiro G; Lopes L; Ribeiro H; Pinto-Basto J; Lima MR; Lacerda L
    J Inherit Metab Dis; 2006 Dec; 29(6):743-54. PubMed ID: 17063374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene.
    Casamassa A; Zanetti A; Ferrari D; Lombardi I; Galluzzi G; D'Avanzo F; Cipressa G; Bertozzi A; Torrente I; Vescovi AL; Tomanin R; Rosati J
    Stem Cell Res; 2022 Aug; 63():102846. PubMed ID: 35759972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II.
    Chkioua L; Khedhiri S; Ferchichi S; Tcheng R; Chahed H; Froissart R; Vianey-Saban C; Laradi S; Miled A
    Diagn Pathol; 2011 May; 6():42. PubMed ID: 21605424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auditory characteristics and therapeutic effects of enzyme replacement in mouse model of the mucopolysaccharidosis (MPS) II.
    Hong SH; Chu H; Kim KR; Ko MH; Kwon SY; Moon IJ; Chung WH; Cho YS; Kim CH; Suh MW; Choi EW; Sohn YB; Park SW; Kim SH; Cho SY; Ko AR; Jin DK
    Am J Med Genet A; 2012 Sep; 158A(9):2131-8. PubMed ID: 22847837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II.
    Wakabayashi T; Shimada Y; Akiyama K; Higuchi T; Fukuda T; Kobayashi H; Eto Y; Ida H; Ohashi T
    Hum Gene Ther; 2015 Jun; 26(6):357-66. PubMed ID: 25761450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological property, mechanism of action and clinical study results of Pabinafusp Alfa (Genetical Recombination) (IZCARGO
    Yamamoto R; Kawashima S
    Nihon Yakurigaku Zasshi; 2022; 157(1):62-75. PubMed ID: 34980815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type II.
    Johnson BA; van Diggelen OP; Dajnoki A; Bodamer OA
    Curr Protoc Hum Genet; 2013 Oct; 79():17.14.1-17.14.9. PubMed ID: 24510650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of 9 novel IDS gene mutations in 19 unrelated Hunter syndrome (mucopolysaccharidosis Type II) patients. Mutations in brief no. 202. Online.
    Karsten SL; Voskoboeva E; Carlberg BM; Kleijer WJ; Tsnnesen T; Pettersson U; Bondeson ML
    Hum Mutat; 1998; 12(6):433. PubMed ID: 10671065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucopolysaccharidosis type II in a female patient with a reciprocal X;9 translocation and skewed X chromosome inactivation.
    Lonardo F; Di Natale P; Lualdi S; Acquaviva F; Cuoco C; Scarano F; Maioli M; Pavone LM; Di Gregorio G; Filocamo M; Scarano G
    Am J Med Genet A; 2014 Oct; 164A(10):2627-32. PubMed ID: 25044788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction.
    Podetz-Pedersen KM; Laoharawee K; Singh S; Nguyen TT; Smith MC; Temme A; Kozarsky K; McIvor RS; Belur LR
    Hum Gene Ther; 2023 Jan; 34(1-2):8-18. PubMed ID: 36541357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel iduronate 2-sulfatase mutation in a Chinese family with mucopolysaccharidosis type II.
    Li XY; Shi XY; Ju J; Hu XH; Yang XF; Zou LP
    World J Pediatr; 2012 Aug; 8(3):281-3. PubMed ID: 22622771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of 11 novel mutations in 49 Korean patients with mucopolysaccharidosis type II.
    Sohn YB; Ki CS; Kim CH; Ko AR; Yook YJ; Lee SJ; Kim SJ; Park SW; Yeau S; Kwon EK; Han SJ; Choi EW; Lee SY; Kim JW; Jin DK
    Clin Genet; 2012 Feb; 81(2):185-90. PubMed ID: 21291454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II.
    Osaki Y; Matsuhisa K; Che W; Kaneko M; Asada R; Masaki T; Imaizumi K; Saito A
    Biochem Biophys Res Commun; 2019 Jun; 514(1):217-223. PubMed ID: 31029429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and structure characterization of novel IDS variants causing mucopolysaccharidosis type II: A retrospective analysis of 30 Chinese children.
    Zhao XY; Qiao GM; Liu F
    Clin Chim Acta; 2021 Dec; 523():386-394. PubMed ID: 34670126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.